Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Steve Sparenborg"'
Autor:
Christie Thomas, Stephen Ross, William Swafford, P. Todd Korthuis, Carolyn Schuman, Gregory S. Brigham, Abigail G. Matthews, Larissa J. Mooney, Steve Sparenborg, Maureen Hillhouse, Michael A. Dawes, Karen Drexler, David Liu, William Lawson, Sarah Church, Andrew J. Saxon, Walter Ling, Patricia C. Knox, John Rotrosen, Jennifer McCormack, Alfonso Ang, Jeffrey J. Annon, Albert Hasson, Katharina Wiest
Publikováno v:
Addiction. 111:1416-1427
Aims To examine the safety and effectiveness of buprenorphine + naloxone sublingual tablets (BUP, as Suboxone(®) ) provided after administration of extended-release injectable naltrexone (XR-NTX, as Vivitrol(®) ) to reduce cocaine use in participan
Autor:
Prasad Kothari, David Styers, Steve Sparenborg, Robert Lindblad, Carmen Rosa, Maria Campanella
Publikováno v:
The American Journal of Drug and Alcohol Abuse. 37:440-445
Background: Reporting all adverse events (AEs) and serious adverse events (SAEs) in substance use disorder (SUD) clinical trials has yielded limited relevant safety information and has been burdensome to research sites. Objective: This article descri
Autor:
Walter, Ling, Maureen P, Hillhouse, Andrew J, Saxon, Larissa J, Mooney, Christie M, Thomas, Alfonso, Ang, Abigail G, Matthews, Albert, Hasson, Jeffrey, Annon, Steve, Sparenborg, David S, Liu, Jennifer, McCormack, Sarah, Church, William, Swafford, Karen, Drexler, Carolyn, Schuman, Stephen, Ross, Katharina, Wiest, P Todd, Korthuis, William, Lawson, Gregory S, Brigham, Patricia C, Knox, Michael, Dawes, John, Rotrosen
Publikováno v:
Addiction (Abingdon, England). 111(8)
To examine the safety and effectiveness of buprenorphine + naloxone sublingual tablets (BUP, as Suboxone(®) ) provided after administration of extended-release injectable naltrexone (XR-NTX, as Vivitrol(®) ) to reduce cocaine use in participants wh
Autor:
Robert Lindblad, Susan C. Sonne, Steve Sparenborg, Theresa Winhusen, Kathleen M. Carroll, Gregory S. Brigham, Roger D. Weiss, Erin A. McClure, Colleen Allen, Aimee L. McRae-Clark, Gaurav Sharma, Kevin M. Gray, Paul Van Veldhuisen, Ryan Vandrey, Frances R. Levin, Larissa J. Mooney, Louise Haynes, Albert Hasson, Abigail G. Matthews, Udi E. Ghitza
Publikováno v:
Contemporary clinical trials. 39(2)
Despite recent advances in behavioral interventions for cannabis use disorders, effect sizes remain modest, and few individuals achieve long-term abstinence. One strategy to enhance outcomes is the addition of pharmacotherapy to complement behavioral
Autor:
Larissa J. Mooney, Steve Sparenborg, Albert Hasson, Christie Thomas, Robrina Walker, Maureen Hillhouse, Jeffrey J. Annon, Linda Chang, Walter Ling, Mark Oyama
Publikováno v:
Drug and Alcohol Dependence. 156:e168
Aims: The observation that dual blockade of endogenous cannabinoid degradative enzymes monoacylglycerol (MAGL) and fatty acid amide hydrolase (FAAH) elicits THC-like psychotropic effects suggest FAAH & MAGL function as dual brakes in curtailing the p
Publikováno v:
Substance Abuse and Rehabilitation
A great divide currently exists between mainstream health care and specialty substance use disorders (SUD) treatment, concerning the coordination of care and sharing of medical information. Improving the coordination of SUD treatment with other disci